{"id": "article-23905_0", "title": "Kleihauer Betke Test -- Introduction", "content": "Fetomaternal hemorrhage (FMH)\u00a0occurs when there is a break in the placental barrier, allowing blood from the fetal circulation to enter the maternal circulation. This disruption in the placental barrier may occur for many reasons, including intrauterine fetal demise and trauma. Trauma is the number\u00a01 cause of pregnancy-associated maternal deaths in the United States. [1] It occurs in as many as 40% of traumas, increasing in frequency and amount with high-force trauma, blunt-force trauma, abdominal trauma, and anterior placental placement in the uterus.", "contents": "Kleihauer Betke Test -- Introduction. Fetomaternal hemorrhage (FMH)\u00a0occurs when there is a break in the placental barrier, allowing blood from the fetal circulation to enter the maternal circulation. This disruption in the placental barrier may occur for many reasons, including intrauterine fetal demise and trauma. Trauma is the number\u00a01 cause of pregnancy-associated maternal deaths in the United States. [1] It occurs in as many as 40% of traumas, increasing in frequency and amount with high-force trauma, blunt-force trauma, abdominal trauma, and anterior placental placement in the uterus."}
{"id": "article-23905_1", "title": "Kleihauer Betke Test -- Introduction", "content": "When FMH occurs, fetal hemoglobin (HbF) is mixed with maternal blood. In response to this exposure, the maternal immune system is activated, and isoimmunization (formation of anti-RhD antibodies) may occur if the mother is Rhesus-D protein (RhD) negative and the blood type of the fetus is RhD positive. It takes only 0.01 ml to 0.03 ml of FMH for the isoimmunization of the mother . Future pregnancies may be at risk for RhD disease if the fetus is RhD-positive.\u00a0The maternal antibodies bind to fetal RhD-positive erythrocytes, leading to hemolysis, anemia, hydrops fetalis, and possibly fetal death.", "contents": "Kleihauer Betke Test -- Introduction. When FMH occurs, fetal hemoglobin (HbF) is mixed with maternal blood. In response to this exposure, the maternal immune system is activated, and isoimmunization (formation of anti-RhD antibodies) may occur if the mother is Rhesus-D protein (RhD) negative and the blood type of the fetus is RhD positive. It takes only 0.01 ml to 0.03 ml of FMH for the isoimmunization of the mother . Future pregnancies may be at risk for RhD disease if the fetus is RhD-positive.\u00a0The maternal antibodies bind to fetal RhD-positive erythrocytes, leading to hemolysis, anemia, hydrops fetalis, and possibly fetal death."}
{"id": "article-23905_2", "title": "Kleihauer Betke Test -- Introduction", "content": "To prevent the formation of anti-RhD antibodies, Rho(D) immune globulin is indicated. Before 12 weeks gestational age, in the setting of an RhD-negative mother and FMH, a mini-dose of 150 mcg Rho(D) immune globulin is given. This dose suppresses the immune response to 2.5 mL of Rh-positive red blood cells. After 12 weeks gestational age, a dose of 300 mcg is recommended. This standard dose of Rho(D) immune globulin (300 mcg) covers FMH up to 15 mL of fetal red cells (30 mL of whole fetal blood). However, there are times when an additional dose is necessary due to massive red blood cell FMH and subsequent maternal immune response. This is when the Kleihauer-Betke (KB) test is essential.", "contents": "Kleihauer Betke Test -- Introduction. To prevent the formation of anti-RhD antibodies, Rho(D) immune globulin is indicated. Before 12 weeks gestational age, in the setting of an RhD-negative mother and FMH, a mini-dose of 150 mcg Rho(D) immune globulin is given. This dose suppresses the immune response to 2.5 mL of Rh-positive red blood cells. After 12 weeks gestational age, a dose of 300 mcg is recommended. This standard dose of Rho(D) immune globulin (300 mcg) covers FMH up to 15 mL of fetal red cells (30 mL of whole fetal blood). However, there are times when an additional dose is necessary due to massive red blood cell FMH and subsequent maternal immune response. This is when the Kleihauer-Betke (KB) test is essential."}
{"id": "article-23905_3", "title": "Kleihauer Betke Test -- Specimen Collection", "content": "The specimen is collected from the maternal patient. This is done through a peripheral venous phlebotomy.", "contents": "Kleihauer Betke Test -- Specimen Collection. The specimen is collected from the maternal patient. This is done through a peripheral venous phlebotomy."}
{"id": "article-23905_4", "title": "Kleihauer Betke Test -- Procedures", "content": "In 1864, Korber noted that HbF was resistant to alkali denaturation with NaOH, much more so than adult hemoglobin (HbA). It was further determined that, when immersed in a citrate buffer pH of 3.3, the HbF remained intact\u00a0while the HbA leaked out. Utilizing this property, the KB test\u00a0was first described in 1957 by\u00a0Enno Kleihauer and Klaus Betker. [2] The KB test is an acid-elution assay performed on maternal blood to determine the amount of HbF that has passed into the maternal circulation. The process exposes maternal blood smears to an acid solution. HbF, resistant to the acid, remains intact, whereas HbA is removed. Following this, the smear is stained via Shepard\u2019s method*. The fetal red blood cells are left rose-pink in color, and the maternal cells appear \u201cghost-like\u201d due to the absence of staining. Though manual detection and quantification had been widely used, flow cytometry was more precise*\u00a0and now may be utilized. A total of 2000 cells is counted. Calculating the fetal to maternal cells percentage is used to estimate the total amount of FMH. [3] The calculation is: percentage of fetal cells = number of fetal cells X 100 / total number of RBCs.", "contents": "Kleihauer Betke Test -- Procedures. In 1864, Korber noted that HbF was resistant to alkali denaturation with NaOH, much more so than adult hemoglobin (HbA). It was further determined that, when immersed in a citrate buffer pH of 3.3, the HbF remained intact\u00a0while the HbA leaked out. Utilizing this property, the KB test\u00a0was first described in 1957 by\u00a0Enno Kleihauer and Klaus Betker. [2] The KB test is an acid-elution assay performed on maternal blood to determine the amount of HbF that has passed into the maternal circulation. The process exposes maternal blood smears to an acid solution. HbF, resistant to the acid, remains intact, whereas HbA is removed. Following this, the smear is stained via Shepard\u2019s method*. The fetal red blood cells are left rose-pink in color, and the maternal cells appear \u201cghost-like\u201d due to the absence of staining. Though manual detection and quantification had been widely used, flow cytometry was more precise*\u00a0and now may be utilized. A total of 2000 cells is counted. Calculating the fetal to maternal cells percentage is used to estimate the total amount of FMH. [3] The calculation is: percentage of fetal cells = number of fetal cells X 100 / total number of RBCs."}
{"id": "article-23905_5", "title": "Kleihauer Betke Test -- Indications", "content": "Kleihauer Betke testing has obstetrical implications in the diagnosis and prognosis of preterm labor, fetal demise, and other conditions.\u00a0There is some controversy on KB testing in the setting of trauma in pregnancy. This test has been historically only recommended for Rh-negative pregnant patients with major trauma. However, the term \"major\" is not specifically defined by most authors. Intuitively, however, the risk of FMH would increase with higher magnitude blunt force, anterior placental location, and coagulopathies, among other factors. Some advocate its use in all pregnant trauma patients, including those who are RhD-negative. It has been shown that a positive KB test accurately predicts the risk of preterm labor following trauma, whereas clinical assessment does not. [4] Because this is an independent risk factor, many authors recommended routine use in the setting of trauma, regardless of Rh status and the mechanism or force of the trauma. The result then is used to guide management and education on prognosis. [5] [6] [7] [6] [5]", "contents": "Kleihauer Betke Test -- Indications. Kleihauer Betke testing has obstetrical implications in the diagnosis and prognosis of preterm labor, fetal demise, and other conditions.\u00a0There is some controversy on KB testing in the setting of trauma in pregnancy. This test has been historically only recommended for Rh-negative pregnant patients with major trauma. However, the term \"major\" is not specifically defined by most authors. Intuitively, however, the risk of FMH would increase with higher magnitude blunt force, anterior placental location, and coagulopathies, among other factors. Some advocate its use in all pregnant trauma patients, including those who are RhD-negative. It has been shown that a positive KB test accurately predicts the risk of preterm labor following trauma, whereas clinical assessment does not. [4] Because this is an independent risk factor, many authors recommended routine use in the setting of trauma, regardless of Rh status and the mechanism or force of the trauma. The result then is used to guide management and education on prognosis. [5] [6] [7] [6] [5]"}
{"id": "article-23905_6", "title": "Kleihauer Betke Test -- Indications", "content": "A study found that the KB\u00a0test was not useful to screen for fetal anemia, but instead, it could be used to explain fetal anemia. [8] Research has also shown the decreased usefulness of systemic KB test after an external cephalic version for breech presentation and in the case of reduced fetal movement during pregnancy. [9] [10] [9]", "contents": "Kleihauer Betke Test -- Indications. A study found that the KB\u00a0test was not useful to screen for fetal anemia, but instead, it could be used to explain fetal anemia. [8] Research has also shown the decreased usefulness of systemic KB test after an external cephalic version for breech presentation and in the case of reduced fetal movement during pregnancy. [9] [10] [9]"}
{"id": "article-23905_7", "title": "Kleihauer Betke Test -- Potential Diagnosis", "content": "The rosette test is a qualitative screening test performed on a maternal blood sample to determine if FMH has occurred between an Rh-positive fetus and an Rh-negative mother and serves as a useful screening test. Qualitative testing may be utilized before quantitative testing, ie, if the rosette test is positive, a KB test should be performed to confirm and then subsequently quantify the amount of FMH. In massive trauma, the KB test may be utilized primarily without the preliminary use of the screening rosette test. The\u00a0Kleihauer Betke test is utilized to determine if there is fetal blood in maternal circulation, with a threshold of 5 mL.", "contents": "Kleihauer Betke Test -- Potential Diagnosis. The rosette test is a qualitative screening test performed on a maternal blood sample to determine if FMH has occurred between an Rh-positive fetus and an Rh-negative mother and serves as a useful screening test. Qualitative testing may be utilized before quantitative testing, ie, if the rosette test is positive, a KB test should be performed to confirm and then subsequently quantify the amount of FMH. In massive trauma, the KB test may be utilized primarily without the preliminary use of the screening rosette test. The\u00a0Kleihauer Betke test is utilized to determine if there is fetal blood in maternal circulation, with a threshold of 5 mL."}
{"id": "article-23905_8", "title": "Kleihauer Betke Test -- Potential Diagnosis", "content": "The rosette test is performed by incubating the Rh-negative maternal venous whole blood sample with anti-Rho(D) immune globulin. The maternal cells are left unbound to the\u00a0anti-Rho(D) as they are Rho(D) negative. During this incubation period, any Rh-positive fetal cells in the maternal sample are sensitized to the anti-Rho(D) immune globulin and bound. Enzyme treated indicator cells are added, only binding to the fetal cells that were present and sensitized, resulting in a process called erythrocyte rosetting or E-rosetting. The indicator cells\u00a0are at the center of the rosette, while the fetal RBCs are clustered around the edges, like petals on a flower. This rosetting pattern may then be viewed under microscopy. Kleihauer Betke test is utilized to determine if there is fetal blood in maternal circulation, with a threshold of 5 mL.", "contents": "Kleihauer Betke Test -- Potential Diagnosis. The rosette test is performed by incubating the Rh-negative maternal venous whole blood sample with anti-Rho(D) immune globulin. The maternal cells are left unbound to the\u00a0anti-Rho(D) as they are Rho(D) negative. During this incubation period, any Rh-positive fetal cells in the maternal sample are sensitized to the anti-Rho(D) immune globulin and bound. Enzyme treated indicator cells are added, only binding to the fetal cells that were present and sensitized, resulting in a process called erythrocyte rosetting or E-rosetting. The indicator cells\u00a0are at the center of the rosette, while the fetal RBCs are clustered around the edges, like petals on a flower. This rosetting pattern may then be viewed under microscopy. Kleihauer Betke test is utilized to determine if there is fetal blood in maternal circulation, with a threshold of 5 mL."}
{"id": "article-23905_9", "title": "Kleihauer Betke Test -- Normal and Critical Findings", "content": "Any value not reported as zero is abnormal. This value also indicates FMH.", "contents": "Kleihauer Betke Test -- Normal and Critical Findings. Any value not reported as zero is abnormal. This value also indicates FMH."}
{"id": "article-23905_10", "title": "Kleihauer Betke Test -- Interfering Factors", "content": "In the case of maternal persistence of fetal hemoglobin or other maternal hemoglobinopathies that result in elevated HbF, the KB test is falsely positive. Also, flow cytometry must be used to quantify the amount of fetal hemorrhage in maternal circulation.", "contents": "Kleihauer Betke Test -- Interfering Factors. In the case of maternal persistence of fetal hemoglobin or other maternal hemoglobinopathies that result in elevated HbF, the KB test is falsely positive. Also, flow cytometry must be used to quantify the amount of fetal hemorrhage in maternal circulation."}
{"id": "article-23905_11", "title": "Kleihauer Betke Test -- Complications", "content": "The KB test is highly specific, with low sensitivity, having a\u00a0threshold of 5 mL\u00a0of FMH to be positive. Remember that the amount of FMH to cause isoimmunization is only 0.01 mL to 0.03 mL. As such, it is\u00a0not\u00a0a test to determine if there is FMH but rather to better estimate the amount of FMH. If positive, it is used to determine additional Rho(D) immune globulin dosing over the standard 150 or 300 mcg dosage that should be administered.", "contents": "Kleihauer Betke Test -- Complications. The KB test is highly specific, with low sensitivity, having a\u00a0threshold of 5 mL\u00a0of FMH to be positive. Remember that the amount of FMH to cause isoimmunization is only 0.01 mL to 0.03 mL. As such, it is\u00a0not\u00a0a test to determine if there is FMH but rather to better estimate the amount of FMH. If positive, it is used to determine additional Rho(D) immune globulin dosing over the standard 150 or 300 mcg dosage that should be administered."}
{"id": "article-23905_12", "title": "Kleihauer Betke Test -- Clinical Significance -- Calculating the RhIg Dosage", "content": "The following calculations should be used to determine an additional number of vials of Rho(D) immune globulin needed if the KB test is positive, indicating a large amount of FMH.\u00a0One vial contains 300 mcg and protects against 30 mL of fetal blood. Volume (mL) of fetal blood = Percentage of fetal cells x 50 Number of Vials of 300 mcg RhIG required = Volume of fetal blood/30 mL Combining equations:\u00a0Number\u00a0of vials* = Percentage of fetal cells x 50 / 30 * If the number to the right of the decimal point is less than 5, round down and add\u00a01 vial. * If the number to the right of the decimal point is greater than or equal to 5, round up and add\u00a01 vial. Example 1:\u00a0 If 2.9% of fetal cells are reported on KB, what dose of RhIG would be required? Volume of fetal blood:\u00a0 2.9 x 50 = 145 mL Number of vials = 145 mL/30 = 4.83 The decimal is greater than 5; therefore, round up and add 1 vial (5+1). Answer: 6 vials", "contents": "Kleihauer Betke Test -- Clinical Significance -- Calculating the RhIg Dosage. The following calculations should be used to determine an additional number of vials of Rho(D) immune globulin needed if the KB test is positive, indicating a large amount of FMH.\u00a0One vial contains 300 mcg and protects against 30 mL of fetal blood. Volume (mL) of fetal blood = Percentage of fetal cells x 50 Number of Vials of 300 mcg RhIG required = Volume of fetal blood/30 mL Combining equations:\u00a0Number\u00a0of vials* = Percentage of fetal cells x 50 / 30 * If the number to the right of the decimal point is less than 5, round down and add\u00a01 vial. * If the number to the right of the decimal point is greater than or equal to 5, round up and add\u00a01 vial. Example 1:\u00a0 If 2.9% of fetal cells are reported on KB, what dose of RhIG would be required? Volume of fetal blood:\u00a0 2.9 x 50 = 145 mL Number of vials = 145 mL/30 = 4.83 The decimal is greater than 5; therefore, round up and add 1 vial (5+1). Answer: 6 vials"}
{"id": "article-23905_13", "title": "Kleihauer Betke Test -- Clinical Significance -- Calculating the RhIg Dosage", "content": "Example 2:\u00a0 If 2.6% of fetal cells are reported on KB, what dose of RhIG would be required? Volume of fetal blood: 2.6% x 50 = 130 mL Number of vials = 130 mL/30 = 4.33 The decimal is less than 5; therefore, round down and add 1 vial (4+1). Answer: 5 vials", "contents": "Kleihauer Betke Test -- Clinical Significance -- Calculating the RhIg Dosage. Example 2:\u00a0 If 2.6% of fetal cells are reported on KB, what dose of RhIG would be required? Volume of fetal blood: 2.6% x 50 = 130 mL Number of vials = 130 mL/30 = 4.33 The decimal is less than 5; therefore, round down and add 1 vial (4+1). Answer: 5 vials"}
{"id": "article-23905_14", "title": "Kleihauer Betke Test -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Kleihauer Betke Test -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}